Pu Fengling

Articles:  1-1 of 1

  • Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

    Uehiro Natsue , Sato Fumiaki , Pu Fengling , Tanaka Sunao , Kawashima Masahiro , Kawaguchi Kosuke , Sugimoto Masahiro , Saji Shigehira , Toi Masakazu

    Background: Circulating cell-free DNA (cfDNA) has recently been recognized as a resource for biomarkers of cancer progression, treatment response, and drug resistance. However, few have demonstrated t …

    Breast Cancer Research 18(1), 2016-12-19

    IR 

Page Top